IDEXX Laboratories, Inc. (LON:0J8P)
705.14
+5.87 (0.84%)
Dec 15, 2025, 4:13 PM BST
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.11B USD in the quarter ending September 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $4.17B, up 8.39% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$4.17B
Revenue Growth
+8.39%
P/S Ratio
13.48
Revenue / Employee
$378.86K
Employees
11,000
Market Cap
41.80B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
| Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
| Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
| Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
| Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
| Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
| Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
| Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
| Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
| Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
| Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
| Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
| Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
| Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
| Dec 31, 2005 | 638.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
IDEXX Laboratories News
- 4 days ago - $1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today - Benzinga
- 6 days ago - Barclays Initiates Coverage on IDEXX Laboratories (IDXX) with Overweight Rating | IDXX Stock News - GuruFocus
- 12 days ago - Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue? - Nasdaq
- 14 days ago - If You Invested $1000 in Idexx Laboratories 10 Years Ago, This Is How Much You'd Have Now - Nasdaq
- 17 days ago - What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now? - Nasdaq
- 17 days ago - Idexx (IDXX) Upgraded to Buy: Here's What You Should Know - Nasdaq
- 20 days ago - P/E Ratio Insights for IDEXX Laboratories - Benzinga
- 21 days ago - IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes